LCST of various DAHBC could be adjusted from 35.4 °C to 42.1 °C.
Lower DS of DOCA lead to Higher LCST.
The DAHBC NPs had high antitumor drugs encapsulation efficiency.
The DAHBC NPs displayed thermal-responsive drug release profiles.
CUR-loaded DAHBC NPs significantly inhibited cells growth at 43 °C (>LCST).